Washington, D.C. – Today, bipartisan legislation authored by U.S. Senators Susan Collins (R-ME) and Claire McCaskill (D-MO) to ban the use of pharmacy “gag clauses” was signed into law.  The Patient Right to Know Drug Prices Act prohibits an egregious practice that concealed lower prescription drug prices from patients at the pharmacy and caused consumers to needlessly overpay.  This legislation is a continuation of Senators Collins and McCaskill’s bipartisan efforts to reduce the cost of prescription drugs.

Washington, D.C.—U.S. Senators Susan Collins and Angus King announced today that 17 community health centers in Maine will receive a total of $4,980,138 through the Health Resources and Services Administration (HRSA) Expanding Access to Quality Substance Use Disorder and Mental Health Services (SUD-MH) awards.  This funding will better equip health centers to help individuals and families overcome substance use disorders and improve mental health.  

Senator Collins’ provisions would reduce diversion of prescription drugs and support long-term recovery

 Since the beginning of this year, Congress has approved approximately $8.4 billion to combat the opioid crisis

Washington, DC — U.S. Senators Susan Collins (R-Maine) and Bob Casey (D-PA), the Chairman and Ranking Member of the Special Committee on Aging, along with U.S.

Washington, D.C. ­– U.S.

Washington, D.C. – Today, U.S.

Washington, D.C. – Today, the Senate Health Committee unanimously passed legislation authored by U.S.

Washington, D.C. - U.S. Senator Susan Collins issued this statement following today’s announcement by the Administration that it is exploring how to safely import prescription drugs from other countries in the event of a dramatic price increase for a drug produced by one manufacturer and not protected by a patent.  Department of Health and Human Services Secretary Alex Azar asked Food and Drug Administration Commissioner Scott Gottlieb to establish a working group on this topic.

WASHINGTON, D.C. – Today, U.S. Senators Susan Collins (R-Maine), the founder and co-chair of the Congressional Task Force on Alzheimer’s disease, and Angus King (I-Maine) announced that The Jackson Laboratory in Bar Harbor has been awarded $873,647 for the year to study the progression and genetic causes of Alzheimer’s. The award is a part of a five-year allocation that will ultimately amount to $4,191,258 by 2023. The funds were awarded by the U.S. Department of Health and Human Services’ (DHHS) National Institute on Aging.

WASHINGTON, D.C. – U.S. Senators Susan Collins and Angus King announced that the U.S. Department of Health and Human Services (HHS) has awarded $1,021,441 to the Maine Primary Care Association (MPCA).  This funding was allocated through the Department’s Health Resources and Services Administration (HRSA).

Washington, D.C. - The Senate Judiciary Committee passed legislation, cosponsored by U.S. Senator Susan Collins, to address the rising costs of prescription drugs.  The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act would deter pharmaceutical companies from blocking lower-cost generic alternatives from entering the marketplace. 

Washington, D.C. — U.S.

Click HERE to watch Senator Collins’ Q&A with Ms. Maxwell